Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024;97(1):31-74.
doi: 10.3233/JAD-230527.

Sex and Sleep Disruption as Contributing Factors in Alzheimer's Disease

Carrie E Johnson  1 , Marilyn J Duncan  2 , M Paul Murphy  1   3
Affiliations
Review

Sex and Sleep Disruption as Contributing Factors in Alzheimer's Disease

Carrie E Johnson et al. J Alzheimers Dis. 2024.

Abstract

Alzheimer's disease (AD) affects more women than men, with women throughout the menopausal transition potentially being the most under researched and at-risk group. Sleep disruptions, which are an established risk factor for AD, increase in prevalence with normal aging and are exacerbated in women during menopause. Sex differences showing more disrupted sleep patterns and increased AD pathology in women and female animal models have been established in literature, with much emphasis placed on loss of circulating gonadal hormones with age. Interestingly, increases in gonadotropins such as follicle stimulating hormone are emerging to be a major contributor to AD pathogenesis and may also play a role in sleep disruption, perhaps in combination with other lesser studied hormones. Several sleep influencing regions of the brain appear to be affected early in AD progression and some may exhibit sexual dimorphisms that may contribute to increased sleep disruptions in women with age. Additionally, some of the most common sleep disorders, as well as multiple health conditions that impair sleep quality, are more prevalent and more severe in women. These conditions are often comorbid with AD and have bi-directional relationships that contribute synergistically to cognitive decline and neuropathology. The association during aging of increased sleep disruption and sleep disorders, dramatic hormonal changes during and after menopause, and increased AD pathology may be interacting and contributing factors that lead to the increased number of women living with AD.

Keywords: Alzheimer’s disease; hormones; menopause; sex differences; sleep; women.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

M. PAUL MURPHY, M.A., PH.D. is an Editorial Board Member of this journal, but was not involved in the peer-review process nor had access to any information regarding its peer-review.

Figures

Fig. 1.
Fig. 1.. Relationship between sleep, hormones, and AD pathology in women.
Estradiol levels begin to decline pre-menopause, while FSH levels begin to rise. Sleep disruptions become prominent during the menopausal transition, about the time when Aβ levels in the brain begin to increase, followed later by an increase in tau. Although some cognitive issues may start in late menopause, the majority of AD-related cognitive decline occurs post-menopausal. Created with BioRender.com.
Fig. 2
Fig. 2. Relationship between circulating hormone levels and sleep disruptions during reproductive years in women and female rodents.
In reproductive years of women and female rodents, circulating levels of gonadal hormones (estrogen and progesterone) and gonadotropins (LH and FSH) rise and fall in accordance with the menstrual (A) and estrous (B) cycle. The majority of sleep disruptions (shown in purple shading) occur in the luteal phase for women in the menstrual cycle, and in the proestrus phase of the estrous cycle for rodents. Comparison of the two suggests that high circulating levels of LH and FSH, and rising levels of progesterone may be correlated with periods of increased sleep disruptions. Created with BioRender.com.
Fig 3.
Fig 3.. Sleep-wake influencing brain regions and AD pathology progression.
Several major brain regions are involved in maintaining states of sleep and wake—PFC (orange), BF (yellow), hypothalamus (green), and the BS (pink). Within the hypothalamus and BS, many sleep-wake influencing nuclei have been identified and are represented as dark grey circles—VLPO/MnPO, SCN, TMN, Orexin neurons, VTA, DRN, LC, PPT, and LDT. Visualizing the progression of both Aβ and tau pathology may be useful in understanding how sleep is affected throughout the course of AD. Many of the areas/nuclei involved in maintaining states of sleep and wake are affected by both Aβ and tau pathology early on in the disease, and worsening pathology with time is often correlated with more dysregulated sleep patterns. Created with Biorender.com.
Fig. 4.
Fig. 4.. Shared characteristics between common sleep disorders and health conditions with increased prevalence in women.
All conditions have been associated with an increased AD risk, increased sleep disruptions, and decreased cognitive functions. They are all increased in prevalence or severity with age, especially throughout the menopausal condition. Additionally, each condition shares many overlapping symptoms, comorbidities, and pathology with AD. Created with BioRender.com.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Organization WH, Dementia https://www.who.int/news-room/fact-sheets/detail/dementia#:~:text=Curren..., 20 September 2022,
    1. (2022) 2022 Alzheimer’s disease facts and figures. Alzheimers Dement 18, 700–789. - PubMed
    1. Rajan KB, Weuve J, Barnes LL, McAninch EA, Wilson RS, Evans DA (2021) Population estimate of people with clinical Alzheimer’s disease and mild cognitive impairment in the United States (2020–2060). Alzheimers Dement 17, 1966–1975. - PMC - PubMed
    1. Vina J, Lloret A (2010) Why women have more Alzheimer’s disease than men: gender and mitochondrial toxicity of amyloid-beta peptide. J Alzheimers Dis 20 Suppl 2, S527–533. - PubMed
    1. Sundermann EE, Biegon A, Rubin LH, Lipton RB, Landau S, Maki PM, Alzheimer’s Disease Neuroimaging I (2017) Does the Female Advantage in Verbal Memory Contribute to Underestimating Alzheimer’s Disease Pathology in Women versus Men? J Alzheimers Dis 56, 947–957. - PMC - PubMed

Publication types